AI and the Pharmaceutical Industry — Weekly 2026-W41
This page is a mechanical aggregation of the daily data and carries no commentary. See the daily pages for interpretation.
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
🧬 Drug Discovery7
- S4 Amount disclosedFrance's Rivercell emerges from stealth with €22 million for AI-powered drug discovery infrastructure€22 million — EU-Startups10/07 23:24 JST
- S4 Amount disclosedIsomorphic Labs aims for $40B+ valuation in new funding, boosting AI drug discovery race.valuation $40B — Pluang10/09 00:25 JSTIsomorphic LabsAlso reported by 2: BigGo Finance · Bloomberg.com
- S4 Amount disclosedAI drug discovery firm Isomorphic in talks to raise funding at a corporate valuation of over $40 billionvaluation $40 billion — Bloomberg.com10/08 14:12 JST
- S4 Amount disclosedU.S. Government and Silicon Valley Giants Pour $1.8 Billion into Closing the AI Drug Discovery Data Gap$1.8 Billion — BigGo Finance10/08 21:25 JST
- S4 Amount disclosedUS government teams up with major Silicon Valley firms to invest $1.8 billion to address data shortage in AI drug discovery$1.8 billion — BigGo ファイナンス10/08 21:25 JST
- S2 Deal / PartnershipRegulatory Service/Supplier jobs in Article Releases Almirall And Absci Announce Ai Drug Discovery Partnership To Rapidly Develop Novel Treatments For Dermatological Diseases | BioSpace — BioSpace10/08 05:42 JSTAbsci
- S4 Amount disclosedPhyraxis AI lands early funding as $3B pours into physical AI for drug discovery$3B — Dealroom10/09 10:28 JST
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance25
- S3 Capital moveCRScube Acquires Mednet to Expand AI-Assisted Data Entry in Clinical Trials — The Clinical Trial Vanguard10/04 21:33 JST
- S1 DeploymentAccelerating Evidence to Action in Pharma with Practical AI Adoption — Emerj Artificial Intelligence Research10/05 20:56 JST
- S4 Amount disclosedTufts' Ken Getz: An AI Clinical Monitor Could Add $21 Million in Value Per Drug Program$21 Million — BigGo Finance10/06 18:08 JST
- S1 DeploymentCompliance concerns hinder rollout of AI in drug manufacturing: Survey — BioSpace10/06 22:13 JST
- S4 Amount disclosedCori Clinical Raises $4M Seed Round Led By Breega For AI Clinical Trial Platform$4M — https://ascendants.in/10/07 21:26 JST
- S4 Amount disclosedEPFL spin-off Baio Labs lands $181,000 grant for AI drug design$181,000 — Dealroom10/07 03:52 JST
- S3 Capital moveTempus AI, Personalis saw US merger antitrust waiting period expire — MLex10/07 06:21 JSTTempus AI
- S2 Deal / PartnershipCognizant Extends Gilead Partnership for Five Years, Will Apply AI to DevOps — Contract Pharma10/07 02:30 JSTGileadAlso reported by 1: Siliconindia
- S2 Deal / PartnershipRegulatory Non-Profit jobs in Article Releases Biotronik Announces Collaboration With Alivecor As First In A Series Of Strategic Partnerships To Disrupt Cardiac Digital Health With Ai Enabled Solutions | BioSpace — BioSpace10/07 10:11 JST
- S1 DeploymentAI Deployment in Clinical Studies Requires Validation Framework and Governance Structure — The Clinical Trial Vanguard10/07 16:29 JST
- S4 Amount disclosedNVIDIA, Eli Lilly Plan Up to $1 Billion for AI Drug Labup to $1 Billion — www.tokenpost.com10/08 23:41 JSTEli Lilly
- S3 Capital moveiM Securities Raises Hanmi Pharmaceutical Target to ₩650,000, Reflecting AI-Designed Obesity Drug Value — BigGo Finance10/08 09:55 JST
- S3 Capital moveNVIDIA's 3-Year $X Investment in 14 AI Pharma Startups: Is a Wave of Star-Studded AI Pharmaceutical IPOs On the Horizon? — 36Kr10/08 14:11 JST
- S2 Deal / PartnershipSeeq Collaborates with Cognizant to Accelerate Industrial AI Adoption in Life Sciences — Morningstar10/08 21:36 JST
- S2 Deal / PartnershipSimulations Plus Announces Funded Partnership with Global Pharmaceutical Company to Advance AI-Enabled QSP Model Development with Turin — Yahoo Finance10/08 22:15 JST
- S2 Deal / PartnershipPRISM BioLab: Hit rate above 70% through proprietary technology and AI, aiming for medium- to long-term growth with pipeline expansion and progress in partnerships with major pharmaceutical companies — dメニューニュース10/08 11:18 JST
- S1 DeploymentJT's corporate R&D organization "D-LAB" adopts medical literature search AI "KIBIT Amanogawa" from FRONTEO — 医薬通信社10/08 17:15 JST
- S4 Amount disclosedKey facts: Tempus AI (TEM) Q2 $382.5M; Oncology Model for AstraZeneca$382.5M — TradingView10/09 16:00 JSTAstraZenecaTempus AI
- S4 Amount disclosedIambic sets IPO terms, seeking $150 million to advance AI-designed cancer drugsplanned $150 million — The Pharma Letter10/09 20:15 JST
- S3 Capital moveSopris Capital Acquires Blackford Analysis from Bayer, Plans Integration with Azra AI — citybiz10/09 23:39 JSTBayer
- S3 Capital moveNvidia-backed AI biotech Iambic seeks up to USD 159m in IPO — MedWatch10/09 17:12 JST
- S2 Deal / PartnershipOxyContin maker Purdue Pharma set to dissolve after $5B sentence; Mayo Clinic AI detects pancreatic cancer years before diagnosis; results of FDA’s largest-ever infant formula test – Morning Medical Update — Medical Economics10/09 20:14 JST
- S1 DeploymentPfizer Handed AI to Its Business Leaders. Adoption Sped Up — Business Model Analyst10/09 21:54 JSTPfizer
- S2 Deal / PartnershipBeijing Haizhi and Jointown Forge AI Partnership for Pharma Distribution Upgrade — The Globe and Mail10/10 20:41 JST
- S1 DeploymentCRB Survey Finds AI Adoption Lagging in Regulated Biopharma Operations — Lab Manager10/10 08:54 JST